The most evidence-based ways to reduce insulin resistance are sustained weight loss when needed, regular aerobic and resistance exercise, a higher-fiber eating pattern, better sleep, and treatment of related conditions such as prediabetes, type 2 diabetes, PCOS, fatty liver disease, sleep apnea, or hepatitis C virus infection. Medication may fit after clinician evaluation 1 2 3 4.
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →What does it mean to reduce insulin resistance?
Insulin resistance means your muscle, liver, and fat cells do not respond to insulin as well as expected. Reducing it means your body can handle glucose with less insulin demand over weeks to months, not that metabolism resets overnight.
Insulin helps move glucose from the blood into cells. When cells resist that signal, the pancreas often makes more insulin to keep fasting glucose normal. That is why someone can have insulin resistance before prediabetes or type 2 diabetes appears on labs 1.
Insulin resistance is often linked with abdominal weight gain, high triglycerides, low HDL cholesterol, fatty liver disease, PCOS, sleep apnea, inactivity, and metabolic syndrome. Some infections and inflammatory states may also matter; in the HALT-C lead-in study, people with chronic hepatitis C and advanced fibrosis had better HOMA2-IR when viral suppression was greater 4.
How it affects hunger, weight, and triglycerides
Insulin resistance can push the body toward higher insulin levels, higher post-meal glucose, more liver triglyceride production, and easier fat storage around the waist. These patterns do not prove a diagnosis by themselves, but they can be useful clues to discuss with a clinician 1.
What are the warning signs of insulin resistance?
Insulin resistance often has no obvious symptoms, so labs matter. Common clues include waist gain, cravings, fatigue after meals, skin tags, acanthosis nigricans, high triglycerides, low HDL cholesterol, high fasting glucose, or elevated A1C 1.
Acanthosis nigricans means darker, thicker, velvety skin, often around the neck or underarms. It can be associated with insulin resistance, but it can also have other causes, so it is a reason for evaluation rather than a self-diagnosis 1.
Which tests can show whether insulin resistance is improving?
A1C and fasting glucose show blood sugar status, while fasting insulin and HOMA-IR can help estimate insulin resistance in some clinical and research settings. A clinician may also track triglycerides, HDL cholesterol, liver enzymes, waist measurement, blood pressure, and weight over 3-month intervals because A1C reflects roughly the prior 2 to 3 months 1.
- A1C: useful for prediabetes and diabetes screening, though it can be affected by anemia, pregnancy, kidney disease, and some blood conditions 3.
- Fasting plasma glucose: a snapshot of glucose after an overnight fast; it can be normal even when postprandial glucose, meaning after-meal glucose, runs high 3.
- Fasting insulin and HOMA-IR: can show insulin demand, but ranges vary by lab and they are not always needed for routine care 1.
- Triglycerides and HDL cholesterol: these can reflect metabolic syndrome risk and often move with changes in diet, activity, weight, and glucose patterns 3.
- Continuous glucose monitors: helpful for seeing food, sleep, stress, and activity patterns, but they do not diagnose insulin resistance by themselves 3.
If fasting glucose is normal but you see high post-meal readings, ask your clinician whether A1C, an oral glucose tolerance test, medication review, sleep apnea screening, or a nutrition plan makes sense for you. Our guide to normal blood sugar ranges explains common fasting, after-meal, and A1C numbers.
Which foods help decrease insulin resistance?
Food changes that help insulin resistance usually reduce glucose spikes, improve fullness, and support weight loss when needed. A practical goal is building most meals around protein, high-fiber carbohydrates, unsaturated fats, and non-starchy vegetables over most days, not following a perfect diet.
Mediterranean-style eating patterns are often recommended because they emphasize vegetables, legumes, whole grains, nuts, olive oil, fish, and minimally processed foods. The Mediterranean Approach to Reduce Insulin Resistance study was designed to test a Mediterranean dietary pattern in insulin-resistant adults, showing that this approach has been studied in this exact metabolic context 5.
- Choose high-fiber carbohydrates such as beans, lentils, oats, barley, fruit, and intact whole grains more often than refined starches.
- Pair carbohydrates with protein, vegetables, and unsaturated fat to slow digestion and blunt some post-meal glucose rises.
- Use olive oil, nuts, seeds, avocado, and fish as common fat sources when they fit your preferences and budget.
- Keep meals repeatable. A simple pattern you can follow for months matters more than a strict plan that lasts one week.
For a more detailed food framework, see our diet chart for prediabetes and our guide to reversing prediabetes.
What foods should I avoid or limit if I have insulin resistance?
Limit foods and drinks that repeatedly cause large glucose swings or make weight loss harder for you. The main targets are sugary drinks, refined grains, sweets, and ultra-processed snack foods; for many people, changing these first gives the most benefit.
- Sugary drinks: soda, sweet tea, juice drinks, sports drinks, and sweet coffee drinks can deliver fast sugar with little fullness.
- Refined grains and sweets: white bread, many cereals, pastries, candy, and desserts may raise post-meal glucose more than higher-fiber options.
- Large portions of low-fiber starches: white rice, fries, chips, and pasta may be fine in some plans, but portion size and pairing matter.
- Alcohol: alcohol can worsen triglycerides, add calories, disrupt sleep, and increase hypoglycemia risk for some people using diabetes medicines 3.
- Saturated-fat-heavy patterns: diets built around processed meats, fried foods, and low-fiber fast foods can work against heart and metabolic goals 3.
The goal is not a banned-food list. The goal is a pattern that improves your labs, hunger, and energy without making daily life feel impossible.
How does exercise reduce insulin resistance?
Exercise helps because working muscle can pull glucose from the blood during activity and remains more insulin-sensitive afterward. Combining aerobic exercise and resistance training is often more useful than relying on one type alone 6.
Aerobic exercise includes brisk walking, cycling, swimming, dancing, and jogging. Resistance training includes weights, machines, bands, or body-weight movements. In a randomized trial in men with obesity, combined aerobic-resistance training was studied as a 12-week metabolic intervention, supporting the idea that structured activity can change metabolic signals 6.
If you are sedentary, have diabetes, have chest pain, have heart disease risk, or use insulin or sulfonylureas, ask your clinician how to start safely. Short walks after meals are often a practical first step because they use muscles when post-meal glucose is rising.
How much does weight loss matter for insulin resistance?
Weight loss can matter a lot when excess visceral fat is a major driver. In the Diabetes Prevention Program, intensive lifestyle intervention in high-risk adults reduced diabetes incidence by 58% compared with placebo over an average 2.8 years, and the program targeted weight loss plus physical activity 2.
Visceral fat is the fat around abdominal organs. It is metabolically active and is linked with insulin resistance, triglycerides, fatty liver disease, and inflammation. Some people see better fasting glucose, triglycerides, blood pressure, or waist size before reaching a goal weight 1.
Weight loss does not fix every glucose pattern. Some people still have post-meal spikes because of beta-cell function, genetics, sleep, stress, medication effects, PCOS, thyroid disease, sleep apnea, or diabetes progression. Our article on losing weight with insulin resistance explains why progress can be uneven.
When can medication fit into reducing insulin resistance?
Medication can fit when lifestyle changes are not enough, when A1C or fasting glucose is rising, when type 2 diabetes is present, or when excess weight is a major driver. The right option depends on diagnosis, BMI, A1C, pregnancy plans, kidney function, side-effect risk, and other medications 3.
Metformin is commonly used for type 2 diabetes and is sometimes considered in prediabetes, especially when risk is high; it lowers liver glucose output and can improve insulin sensitivity in some people 3. You can read more in our guide to metformin for insulin resistance.
GLP-1 receptor agonists include Ozempic — semaglutide — GLP-1 receptor agonist; Wegovy — semaglutide — GLP-1 receptor agonist; dulaglutide — GLP-1 receptor agonist; and liraglutide — GLP-1 receptor agonist. Dual GIP/GLP-1 receptor agonists include Mounjaro — tirzepatide — dual GIP/GLP-1 receptor agonist and Zepbound — tirzepatide — dual GIP/GLP-1 receptor agonist. FDA labels for Wegovy and Zepbound describe chronic weight-management indications for specific patients, along with gastrointestinal side effects and warnings, including pancreatitis and gallbladder disease risks 7 8.
In a randomized trial of adults with obesity and prediabetes, researchers compared weight loss and incretin-based therapies for cardiometabolic outcomes, which supports discussing weight loss and incretin-based treatment as studied approaches in this population 9. Individual results vary, and results from FDA-approved products or study protocols should not be treated as established outcomes for compounded formulations.
Supplements are more uncertain. A 2025 systematic review and meta-analysis of randomized trials reported chromium supplementation reduced HOMA-IR and fasting blood sugar, but did not significantly change HbA1c and had high heterogeneity, meaning trial results varied widely 10. Supplements can also interact with medications or be inappropriate for kidney, liver, pregnancy, or diabetes situations, so they should not replace medical evaluation.
| Situation | Sensible next step | Trade-offs to discuss |
|---|---|---|
| No diagnosis yet, but waist gain, cravings, high triglycerides, or family history | Ask about A1C, fasting glucose, lipids, blood pressure, waist measurement, and related conditions | Symptoms alone cannot diagnose insulin resistance |
| Prediabetes or rising A1C | Lifestyle plan focused on fiber, exercise, sleep, and weight loss when needed; ask whether metformin fits | Medication choice depends on risk, labs, pregnancy plans, and kidney function |
| Type 2 diabetes | Work with a clinician on glucose targets, medications, nutrition, and safe activity | Do not adjust insulin or diabetes medicines without your prescriber |
| Excess weight is a major driver and lifestyle steps are not enough | Ask whether weight-loss medication, including GLP-1 or GIP/GLP-1 treatment, is appropriate | Side effects, contraindications, cost, and long-term plan matter |
| PCOS, fatty liver disease, sleep apnea, thyroid disease, or medication-related weight gain | Evaluate and treat the related driver, not just glucose numbers | Progress may be slower if the root driver is missed |
3-min quiz
Considering weight-loss treatment?
If excess weight is a major driver of insulin resistance, Chia can help eligible patients explore clinician-reviewed weight-loss care with semaglutide injection or tirzepatide tablets or injection. A licensed provider reviews your health history and prescribes only when clinically appropriate; a prescription is not guaranteed. Compounded medications are not FDA-approved.
Weight-loss treatment at Chia: when GLP-1 care may fit
Chia offers weight-loss treatment for eligible patients when a licensed provider decides it is clinically appropriate. Our care is 100% online: you complete a short health questionnaire, a licensed US provider reviews it, and medication is prescribed only when appropriate.
At Chia, available weight-loss options include compounded semaglutide injection and compounded tirzepatide tablets or injection through state-licensed 503A pharmacies. Semaglutide is a GLP-1 receptor agonist; tirzepatide is a dual GIP/GLP-1 receptor agonist. Microdosing plans are available for semaglutide and tirzepatide when clinically appropriate. Compounded medications, compounded tirzepatide tablets, and microdosing protocols are not FDA-approved.
| Chia option | Forms listed in Chia catalog | Current starting price | Who may prefer it |
|---|---|---|---|
| Semaglutide | Injection | Plans currently start at $249/mo | Someone who is comfortable with an injectable GLP-1 plan after provider review |
| Tirzepatide | Tablets or injection | Tablets currently start at $249/mo; injection currently starts at $299/mo | Someone who wants to discuss a dual GIP/GLP-1 option and form preference with a provider |
| Weight + Energy | NAD+ injection plus choice of GLP-1 | Plans currently start at $309/mo | Someone asking about weight care plus an energy-focused longevity protocol |
| Weight + Muscle | Sermorelin injection plus choice of GLP-1 | Plans currently start at $329/mo | Someone asking about weight care plus a muscle-focused longevity protocol |
Chia medications are compounded in the US by state-licensed 503A compounding pharmacies and shipped to the patient’s door. Patients can message their care team through the portal between visits. If you use an AI agent to manage health tasks, Chia’s prescription workflow can also be reached through DoctorMCP at mcp.chia.health, but it is not a shortcut around clinician review.
What is the 3 day rule for insulin?
The 3 day rule usually refers to some diabetes care plans that look for repeated glucose patterns over several days before changing insulin. It is not a universal rule, and insulin users should not apply a rule found online without their prescriber.
Insulin adjustment depends on the type of insulin, meals, illness, kidney function, activity, lows, highs, pregnancy status, and other medications. The ADA Standards of Care emphasize individualized diabetes treatment and medication safety, which is why repeated highs, repeated lows, illness, vomiting, dehydration, or medication changes should prompt contact with a clinician 3.
What should I do first if I want to reduce insulin resistance?
Start by measuring where you are, then choose one food habit and one movement habit you can repeat. Most people learn more from tracking a few markers over 8 to 12 weeks than from trying to change everything at once.
- 1Get baseline labs and context: A1C, fasting glucose, lipid panel, blood pressure, waist measurement, medication review, sleep apnea risk, PCOS symptoms, fatty liver risk, and family history.
- 2Pick one food change: replace sugary drinks, add beans or vegetables at one meal, increase protein at breakfast, or swap refined grains for higher-fiber options.
- 3Pick one movement habit: a 10-minute walk after one meal, two resistance sessions weekly, or a step goal that is realistic from your current baseline.
- 4Track progress: waist, weight, A1C, fasting glucose, post-meal patterns, triglycerides, HDL cholesterol, energy, sleep, and hunger.
- 5Ask about medication if lifestyle steps are not enough, weight is a major driver, or A1C, fasting glucose, or symptoms are worsening.
If you are still trying to understand the basics, start with what insulin resistance is and the common signs of insulin resistance.
3-min quiz
Start a clinician-reviewed weight-loss visit
If weight-loss treatment may fit your situation, you can start Chia’s online visit and have a licensed provider review your health history. Chia offers compounded semaglutide injection, tirzepatide tablets, tirzepatide injection, and related protocols such as Weight + Energy and Weight + Muscle for eligible patients. A prescription requires medical evaluation and is never guaranteed. Compounded medications, compounded tirzepatide tablets, and related NAD+ or sermorelin protocols are not FDA-approved.
FAQ
Some people find time-restricted eating helps them reduce calories and improve glucose patterns. It is not right for everyone, especially people who use insulin or diabetes medicines that can cause low blood sugar, people who are pregnant, and people with a history of eating disorders 3.
Carbs are not all the same. High-fiber carbs like beans, lentils, fruit, and intact whole grains often fit well, while sugary drinks, sweets, and refined grains are more likely to raise glucose quickly 3.
Yes. The pancreas may make extra insulin for years before fasting glucose or A1C becomes abnormal. That is why waist changes, triglycerides, HDL cholesterol, family history, PCOS, fatty liver, and fasting insulin may be part of a clinician’s review 1.
There is no single “better” choice for everyone. Metformin, semaglutide, tirzepatide, and other medications have different indications, side effects, contraindications, costs, and monitoring needs. The right choice depends on diagnosis, labs, weight, kidney function, pregnancy plans, and other medicines 3.
Ask whether your BMI, A1C, medical history, pregnancy plans, kidney and liver health, gallbladder history, pancreatitis history, current medications, and weight-loss goals make medication appropriate. Also ask what side effects to watch for and how follow-up will work 3.
References
- 1.Gutch M, Kumar S, Razi SM, Gupta KK, Gupta A. Assessment of insulin sensitivity/resistance. Indian Journal of Endocrinology and Metabolism. 2015.
- 2.Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine. 2002.
- 3.American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes—2026. Diabetes Care. 2026.
- 4.Del Campo JA, et al. Reduction of insulin resistance with effective clearance of hepatitis C infection: results from the HALT-C trial. Clinical Gastroenterology and Hepatology. 2010.
- 5.ClinicalTrials.gov. MARIS Study; Mediterranean Approach to Reduce Insulin Resistance. NCT00405197. 2007.
- 6.Saedmocheshi S, Dhahbi W, Saeidi A, et al. Combined Aerobic-Resistance Training and Taurine Supplementation Reduce Asprosin and Elevate Spexin in Men with Obesity: A 12-Week Supplement-Blinded, Randomized Controlled Trial. Nutrients. 2026.
- 7.U.S. Food and Drug Administration. WEGOVY (semaglutide) injection, for subcutaneous use. Prescribing Information. 2024.
- 8.U.S. Food and Drug Administration. ZEPBOUND (tirzepatide) injection, for subcutaneous use. Prescribing Information. 2025.
- 9.Mashayekhi M, Beckman JA, Nian H, et al. Comparative effects of weight loss and incretin-based therapies on vascular endothelial function, fibrinolysis and inflammation in individuals with obesity and prediabetes: A randomized controlled trial. Diabetes, Obesity & Metabolism. 2023.
- 10.Fatahi M, Aghajani S, Javaheri H, Toqroljerdi MHF. The Effect of Chromium Supplements on Insulin Resistance: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Journal of Health & Medical Sciences. 2025.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.



